RxSearch

NDC properties for NDC 9 0591-2925

NDC item 00591292530

NDC 90591-2925
NDC 100591-2925-30
NDC Item00591292530
packaging30 PACKET in 1 CARTON (0591-2925-30) / 1.25 g in 1 PACKET (0591-2925-32)
ANDAANDA204570
DCSACIII
FDA SPL set id546325
LabelerActavis Pharma, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryANDA
Marketing effective time low2021-02-12
Marketing statusACTIVE

NDC item 00591292532

NDC 90591-2925
NDC 100591-2925-32
NDC Item00591292532
packaging1.25 g in 1 PACKET
ANDAANDA204570
DCSACIII
FDA SPL set id546325
LabelerActavis Pharma, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryANDA
Marketing effective time low2021-02-12
Marketing statusACTIVE

NDC item 16714096801

NDC 916714-968
NDC 1016714-968-01
NDC Item16714096801
packaging1.25 g in 1 PACKET
ANDAANDA205781
DCSACIII
FDA SPL set id775662
LabelerNorthstar Rx LLC
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryANDA
Marketing effective time low2019-11-06
Marketing statusACTIVE

NDC item 16714096802

NDC 916714-968
NDC 1016714-968-02
NDC Item16714096802
packaging30 PACKET in 1 CARTON (16714-968-02) / 1.25 g in 1 PACKET (16714-968-01)
ANDAANDA205781
DCSACIII
FDA SPL set id775662
LabelerNorthstar Rx LLC
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryANDA
Marketing effective time low2019-11-06
Marketing statusACTIVE

NDC item 45802028103

NDC 945802-281
NDC 1045802-281-03
NDC Item45802028103
packaging1.25 g in 1 PACKET
ANDAANDA205781
DCSACIII
FDA SPL set id784981
LabelerPadagis Israel Pharmaceuticals Ltd
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryANDA
Marketing effective time low2019-06-27
Marketing statusACTIVE

NDC item 45802028139

NDC 945802-281
NDC 1045802-281-39
NDC Item45802028139
packaging30 PACKET in 1 CARTON (45802-281-39) / 1.25 g in 1 PACKET (45802-281-03)
ANDAANDA205781
DCSACIII
FDA SPL set id784981
LabelerPadagis Israel Pharmaceuticals Ltd
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryANDA
Marketing effective time low2019-06-27
Marketing statusACTIVE

NDC item 45802075403

NDC 945802-754
NDC 1045802-754-03
NDC Item45802075403
packaging1.25 g in 1 PACKET (45802-754-03)
ANDAANDA204268
DCSACIII
FDA SPL set id602017
LabelerPadagis Israel Pharmaceuticals Ltd
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryANDA
Marketing effective time low2018-10-12
Marketing statusACTIVE

NDC item 68382036212

NDC 968382-362
NDC 1068382-362-12
NDC Item68382036212
packaging1.25 g in 1 PACKET
DCSACIII
FDA SPL set id676429
LabelerZydus Pharmaceuticals (USA) Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA AUTHORIZED GENERIC
Marketing effective time high2021-08-31
Marketing effective time low2018-10-12
Marketing statusCOMPLETED
NDA_AUTHORIZED_GENERICNDA022309